Literature DB >> 2425781

Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies.

G Abenes, H Kida, R Yanagawa.   

Abstract

Twelve monoclonal antibodies to the F protein of a velogenic strain of Newcastle disease virus (NDV) were established. Each of these antibodies inhibited virus-induced plaque formation in BHK-21 cells. Seven antibodies neutralized viral infectivity in eggs; thus, antigenic variants could be selected with these antibodies and used for antigenic mapping. Based on the reactivity of the antigenic variants with the antibodies used in selection, 4 distinct antigenic sites (I-IV) were defined on the F protein molecule. In competitive binding assay, sites II and III were found to be spatially close to each other. Each antibody to sites I, II and III inhibited both virus-induced hemolysis of chicken erythrocytes and syncytium formation of BHK-21 cells. On the other hand, some of the antibodies to site IV selectively inhibited either hemolysis or cell fusion. This finding may indicate that the fusion of the viral envelope with erythrocytes and host cell membrane is modulated through different ways. Comparative analysis of different NDV strains using monoclonal antibodies to each of the different antigenic sites showed that the antigenicity of the F protein is highly conserved.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425781     DOI: 10.1007/bf01314148

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  43 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Studies on a virus isolated from the brain of a parakeet (Neophema sp).

Authors:  T Smit; P R Rondhuis
Journal:  Avian Pathol       Date:  1976       Impact factor: 3.378

3.  Sequence determination of the Sendai virus fusion protein gene.

Authors:  B M Blumberg; C Giorgi; K Rose; D Kolakofsky
Journal:  J Gen Virol       Date:  1985-02       Impact factor: 3.891

4.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

5.  Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus.

Authors:  H Kida; L E Brown; R G Webster
Journal:  Virology       Date:  1982-10-15       Impact factor: 3.616

6.  The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus.

Authors:  C Orvell; M Grandien
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies.

Authors:  P H Russell; D J Alexander
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 8.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  Insensitivity of a ricin-resistant mutant of Chinese hamster ovary cells to fusion induced by Newcastle disease virus.

Authors:  P G Polos; W R Gallaher
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

10.  Monoclonal antibodies against a paramyxovirus isolated from Japanese Sparrow-Hawks.

Authors:  S Hoshi; T Mikami; K Nagata; M Onuma; H Izawa
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

View more
  11 in total

1.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization.

Authors:  T Toyoda; B Gotoh; T Sakaguchi; H Kida; Y Nagai
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors:  J A Beeler; K van Wyke Coelingh
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Detection of Newcastle disease virus RNA in infected allantoic fluids by in vitro enzymatic amplification (PCR).

Authors:  V Jestin; A Jestin
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Evaluation of the antiviral effect of synthetic oligopeptides whose sequences are derived from paramyxovirus F1 N termini.

Authors:  N M Inocencio; B Gotoh; T Toyoda; C Kitada; Y Nagai
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

6.  Characterization of French avian paramyxovirus type 1 (PMV 1) isolates with a Panel of monoclonal antibodies to the Ploufragan strain of Newcastle disease virus.

Authors:  V Jestin; M Cherbonnel; M Morin; M Guittet; G Bennejean
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3.

Authors:  B Gotoh; Y Ohnishi; N M Inocencio; E Esaki; K Nakayama; P J Barr; G Thomas; Y Nagai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Separate epitopes in the envelope of visna virus are responsible for fusion and neutralization: biological implications for anti-fusion antibodies in limiting virus replication.

Authors:  S E Crane; J E Clements; O Narayan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Protective effect of antibodies to two viral envelope glycoproteins on lethal infection with Newcastle disease virus.

Authors:  Y Umino; T Kohama; M Kohase; A Sugiura; H D Klenk; R Rott
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

10.  A mutant CHO-K1 strain with resistance to Pseudomonas exotoxin A is unable to process the precursor fusion glycoprotein of Newcastle disease virus.

Authors:  N M Inocencio; J M Moehring; T J Moehring
Journal:  J Virol       Date:  1993-01       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.